Asaleo Care Limited reported earnings results for the first six months ended June 30, 2017. For the period, the company reported underlying revenue of AUD 294.2 million against AUD 292.7 million a year ago. Underlying EBITDA was AUD 60.9 million against AUD 58.6 million a year ago. Underlying EBIT was AUD 46.1 million against AUD 43.4 million a year ago. Underlying NPAT was AUD 28.2 million against AUD 27.1 million a year ago. Statutory NPAT was AUD 27.7 million against AUD 24.9 million a year ago. Earnings per share were 5.2 cents against 4.8 cents per share a year ago. Return on equity was 22.3% against 21.0% a year ago. CapEx was AUD 9.2 million.

For the year 2017, the company expects underlying and statutory result is expected to be materially consistent. Expect return to year on year profit growth in fiscal year 2017, despite the second half of 2017 challenges of cost imposts and a competitive retail environment. Full year free cash flow of AUD 85 million to AUD 95 million, inclusive of capital optimisation initiatives and growth capex. The company is forecasting low single-digit growth in underlying EBITDA or NPAT and underlying EPS at low to mid-single-digits and maintenance CapEx to be around AUD 20 million for the full year.